$ATR

Touya Gael sold $500K of ATR

Touya Gael (Segment Pres., CEO Designate) sold 3,740 shares of APTARGROUP, INC. (ATR) at an average of $133.76 ($133.69–$134.55, $0.50M total) across 2 trades on 2026-08-27.

Original reporting
SEC EDGAR · Touya Gael
Published Aug 28, 2026, 2:10 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 28, 2026, 3:03 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ATR
Bearish
medium confidence
Mentioned
$ATR
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ATRBearishLow
01

Why it matters

The disclosed sale reduces insider ownership, which may be interpreted as reduced confidence, but the amount is small relative to ATR's float.

02

Market read

Routine insider sale with modest size; limited trading relevance.

03

What to watch

No 10b5‑1 plan; timing may align with personal tax planning.

Relevance 5/10Novelty 3/10Timing: post‑market on 2026‑08‑27

Background

Form 4 filing discloses insider transactions; such filings are primary sources for insider activity.

Company-level read

Ticker impact

$ATRBearishMedium confidence
Context

CEO-designate Touya Gael sold 3,740 shares for $500,276, reducing his stake to 29,102 shares.

Expected impact

Potential slight dip in ATR price.

Evidence & confidence

Sale size is modest relative to market cap, but insider status adds weight.

Market effects

Minimal impact on packaging and dispensing sector.

No regional effect beyond investor sentiment.

Limited to ATR shareholders.

Counterpoint

Sale could be routine liquidity need, not a bearish signal.

Key entities

  • AptarGroup, Inc.

    Manufacturer of dispensing and packaging solutions, ticker ATR.

  • Touya Gael

    Segment President and CEO Designate of AptarGroup.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ATRMed

Publication of a Circular

Schroder Asian Total Return Investment Company plc (ATR) said it has published a circular for shareholders on a proposed combination with Pacific Assets Trust plc (PAC). The plan would use a scheme of reconstruction and PAC’s members’ voluntary winding-up, transferring most PAC assets and issuing New ATR shares. A cash option is capped at 25% with a 2% discount; shareholder approval is required.

$ATRMedAI 8/10

Aptar (ATR) Q2 2026 Earnings Call Transcript

AptarGroup (ATR) reported Q2 2026 total sales of $1.03B, up 6% reported, with adjusted EPS of $1.42 above guidance. Adjusted EBITDA was $213M, down 3%, and margins fell due to mix and operational issues in beauty. Pharma core sales grew 8% excluding emergency medicine destocking. Net debt was $1.2B, leverage 1.49x, and Q3 adjusted EPS guidance is $1.45 to $1.53.

$ATRMed

APTARGROUP, INC. (ATR): Results of Operations and Financial Condition

APTARGROUP, INC. (ATR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Aptar Reports Second Quarter 2026 Results Crystal Lake, Illinois, July 30, 2026 -- AptarGroup, Inc. (NYSE:ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today reported the following second quarter results